DTx West
The Pivotal Moment for Digital Therapeutics<br>Next-Generation Digital Healthcare
3/13/2025 - March 14, 2025
There is arguably no greater time in the history of the field for us to come together to advance validated digital healthcare. We are at a pivotal point for the field as new billing codes emerge, business models rapidly evolve, and market consolidation continues.
DTx West 2025 is the opportunity to reconnect, reflect, and ultimately continue to drive progress. Digital Therapeutics has faced real challenges but emerging commercialization pathways, new partnership opportunities, and advanced patient understanding are driving forward the next generation of approaches and the core of DTx West 2025.
Evidence-based, clinically validated digital solutions are the focus of the DTx Series. Our shared desire to provide patients with access to these solutions ensures that when we meet, we genuinely impact the field.
DTx West 2025 is the opportunity to reconnect, reflect, and ultimately continue to drive progress. Digital Therapeutics has faced real challenges but emerging commercialization pathways, new partnership opportunities, and advanced patient understanding are driving forward the next generation of approaches and the core of DTx West 2025.
Evidence-based, clinically validated digital solutions are the focus of the DTx Series. Our shared desire to provide patients with access to these solutions ensures that when we meet, we genuinely impact the field.
Thursday, March 13
Registration Open
Networking Breakfast
THE FUTURE OF VALIDATED DIGITAL HEALTHCARE
Organizer's Remarks
Chair's Opening Remarks
KEYNOTE CASE STUDY:
How Software-Enhanced Drugs Will Change the Future of Care
- How can rigorously developed prescription digital therapeutics address the unresolved neurological components of disease, close gaps in care, and maximize treatment success?Â
- What synergies exist between PDTs and pharmacotherapies that create value for pharma, patients, payers, and providers as both standalone and combination treatments?Â
- How will pharma start to digitize their pharmaceutical pipelines given recent draft guidance from FDA on Prescription Drug Use-Related Software (PDURS)?
Panel Moderator:
KEYNOTE PANEL DISCUSSION:
The Digital Therapeutics & The Digital Healthcare Revolution
Panelists:
Coffee Break
STORIES FROM THE FRONT LINE OF HEALTHCARE
CASE STUDY:
Integrating Digital Innovations into Clinical Care—A Clinician's Perspective
Drivers for clinician adoption of digital health tools—improved patient outcomes are not enough. Lessons learned from what's worked and what hasn't. Where to next with DTx?
Panel Moderator:
PANEL DISCUSSION:
Developing the Healthcare Ecosystem for Digital Adoption
Panelists:
Networking Luncheon
THE BUSINESS OF DIGITAL
Panel Moderator:
PANEL DISCUSSION:
Digital and Pharma as One
Panelists:
CASE STUDY: Consolidation in Digital Health for Greater Competitive and Comparative Advantage
During the past several years, we have seen a wholesale transformation of the competitive dynamics of the digital health industry. All companies in the industry have had to completely rethink their revenue and overall business models in a focused drive to profitability. We have seen a natural experiment play out with competing business models, and we now know what seems to work.
- Focus on existing revenue models rather than hoping for ones of the future
- Expand the client offering to deliver more value with less complexityÂ
- Provide an Amazon-like patient experience to deliver on the Triple Aim of Healthcare
Refreshment Break
THE STANDARDS OF “VALIDATED†DIGITAL HEALTHCARE
Panel Moderator:
PANEL DISCUSSION:
Data-Driven Decisions—Shaping the Evidence Standards in “Validated†Digital Healthcare
Panelists:
Close of Day
Friday, March 14
Registration Open
Networking Breakfast
SUCCESS & INVESTMENT
Chair's Opening Remarks
Adam Kaufman, PhD, Interim Category Lead, Products, Baylor Scott & White Health , Interim Category Lead , Products , Baylor Scott & White Health
Panel Moderator:
PANEL DISCUSSION:
PTSD: The Myths, Realities, and Complexity of the Patient Experience
Panelists:
Doug Bartlett, Patient and Senior Vice President, Solventum , Patient and Senior Vice President , Solventum
Panel Moderator:
PANEL DISCUSSION:
The Digital Therapeutics & Digital Health Investment Landscape
Panelists:
Coffee Break
CASE STUDIES & THE FUTURE
CASE STUDY: The Role of Digital Therapeutics in Autism, Neurodevelopment, and Value-Based Care
- From a clinician’s perspective, how can digital therapeutics be most effectively used alongside other therapies in autism (medical testing and treatment, behavioral therapy, developmental therapies, and family support)?
- How can DTx companies work effectively with healthcare providers? (across both research and market launch)
- Which reimbursement mechanisms (including value-based care) allow digital therapeutics to be used by healthcare providers at scale?​
Panel Moderator:
PANEL DISCUSSION:
Machines Have Minds—The Role of AI & Generative Learning in Digital Health
Panelists:
Close of Conference
#DTxWest
